ATE291T1 - Fluorenyl-azolylmethyl-carbinole, verfahren zu ihrer herstellung, arzneimittel, die diese verbindungen enthalten und verfahren zur herstellung dieser arzneimittel. - Google Patents

Fluorenyl-azolylmethyl-carbinole, verfahren zu ihrer herstellung, arzneimittel, die diese verbindungen enthalten und verfahren zur herstellung dieser arzneimittel.

Info

Publication number
ATE291T1
ATE291T1 AT79104485T AT79104485T ATE291T1 AT E291 T1 ATE291 T1 AT E291T1 AT 79104485 T AT79104485 T AT 79104485T AT 79104485 T AT79104485 T AT 79104485T AT E291 T1 ATE291 T1 AT E291T1
Authority
AT
Austria
Prior art keywords
processes
medications
carbinols
azolylmethyl
fluorenyl
Prior art date
Application number
AT79104485T
Other languages
German (de)
English (en)
Inventor
Erik Ing. Grad. Regel
Karl Heinz Prof. Dr. Buechel
Ingo Dr. Haller
Manfred Dr. Plempel
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Application granted granted Critical
Publication of ATE291T1 publication Critical patent/ATE291T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/36—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring increasing the number of carbon atoms by reactions with formation of hydroxy groups, which may occur via intermediates being derivatives of hydroxy, e.g. O-metal
    • C07C29/38—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring increasing the number of carbon atoms by reactions with formation of hydroxy groups, which may occur via intermediates being derivatives of hydroxy, e.g. O-metal by reaction with aldehydes or ketones
    • C07C29/40—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring increasing the number of carbon atoms by reactions with formation of hydroxy groups, which may occur via intermediates being derivatives of hydroxy, e.g. O-metal by reaction with aldehydes or ketones with compounds containing carbon-to-metal bonds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/80—Ketones containing a keto group bound to a six-membered aromatic ring containing halogen
    • C07C49/813—Ketones containing a keto group bound to a six-membered aromatic ring containing halogen polycyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/02—Ortho- or ortho- and peri-condensed systems
    • C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/06—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members
    • C07C2603/10—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings
    • C07C2603/12—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings only one five-membered ring
    • C07C2603/18—Fluorenes; Hydrogenated fluorenes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
AT79104485T 1978-11-25 1979-11-14 Fluorenyl-azolylmethyl-carbinole, verfahren zu ihrer herstellung, arzneimittel, die diese verbindungen enthalten und verfahren zur herstellung dieser arzneimittel. ATE291T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19782851143 DE2851143A1 (de) 1978-11-25 1978-11-25 Fluorenyl-azolylmethyl-carbinole, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
EP79104485A EP0011770B1 (de) 1978-11-25 1979-11-14 Fluorenyl-azolylmethyl-carbinole, Verfahren zu ihrer Herstellung, Arzneimittel, die diese Verbindungen enthalten und Verfahren zur Herstellung dieser Arzneimittel

Publications (1)

Publication Number Publication Date
ATE291T1 true ATE291T1 (de) 1981-10-15

Family

ID=6055604

Family Applications (1)

Application Number Title Priority Date Filing Date
AT79104485T ATE291T1 (de) 1978-11-25 1979-11-14 Fluorenyl-azolylmethyl-carbinole, verfahren zu ihrer herstellung, arzneimittel, die diese verbindungen enthalten und verfahren zur herstellung dieser arzneimittel.

Country Status (8)

Country Link
US (1) US4239765A (pl)
EP (1) EP0011770B1 (pl)
JP (1) JPS5573661A (pl)
AT (1) ATE291T1 (pl)
CA (1) CA1130810A (pl)
DE (2) DE2851143A1 (pl)
ES (1) ES486278A1 (pl)
IL (1) IL58774A (pl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0094146B1 (en) * 1982-04-22 1987-01-14 Zeneca Limited Antifungal azolyl phenyl substituted alicyclic alcohols
US4533670A (en) * 1983-09-21 1985-08-06 Eli Lilly And Company Anti-convulsant fluorenylalkylimidazole derivatives, compositions, and method of use
CA1249832A (en) * 1984-02-03 1989-02-07 Shionogi & Co., Ltd. Azolyl cycloalkanol derivatives and agricultural fungicides
US4859693A (en) * 1988-08-10 1989-08-22 E. I. Du Pont De Nemours And Company Antiinflammatory carbinoloimidazoles
US6037361A (en) * 1998-03-09 2000-03-14 Warner-Lambert Company Fluorinated butyric acids and their derivatives as inhibitors of matrix metalloproteinases
CN109503736A (zh) * 2017-09-15 2019-03-22 常州强力先端电子材料有限公司 芴类光引发剂及包含其的光固化组合物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1964996C3 (de) * 1969-12-24 1978-11-30 Bayer Ag, 5090 Leverkusen 9-Azolyl-fluoren-9-carbonsäure-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Mittel zur Regulierung des Pflanzenwachstums
DE2623129C3 (de) * 1976-05-22 1980-04-10 Nordmark-Werke Gmbh, 2000 Hamburg U-Diphenyl-3-(imidazol-l-yl) -propan-2-ole, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel

Also Published As

Publication number Publication date
IL58774A (en) 1983-09-30
JPS638938B2 (pl) 1988-02-25
CA1130810A (en) 1982-08-31
DE2851143A1 (de) 1980-06-04
ES486278A1 (es) 1980-05-16
EP0011770B1 (de) 1981-10-14
JPS5573661A (en) 1980-06-03
DE2961026D1 (en) 1981-12-24
IL58774A0 (en) 1980-02-29
EP0011770A1 (de) 1980-06-11
US4239765A (en) 1980-12-16

Similar Documents

Publication Publication Date Title
ATE1238T1 (de) Neue 1,4-dihydropyridinverbindungen, verfahren zu ihrer herstellung, die genannten verbindungen enthaltende arzneimittel und verfahren zur herstellung dieser arzneimittel.
ATE851T1 (de) Hydroxyethyl-azole, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel.
ATE29T1 (de) Pyrazolaetherderivate, verfahren zu ihrer herstellung und herbizide, die diese verbindungen enthalten
DE3483629D1 (de) 2-pyrimidinyl-l-piperazin-derivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.
ATE20182T1 (de) Verfahren zur herstellung von tabletten.
ATE324T1 (de) Hydroxypropyl-triazole, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel.
ATE290T1 (de) Fluorhaltige 1,4-dihydropyridine, diese enthaltende arzneimittel sowie verfahren zu ihrer herstellung.
ATE9350T1 (de) Tricyclische cytosinderivate zur verwendung in arzneimitteln und verfahren zu ihrer herstellung.
AT292212B (de) Verfahren zur Herstellung des neuen 7α-Methyl-3,16β,17β-trihydroxy-Δ<1,3,5(10)>-oestratriens
ATE19079T1 (de) Azolyl-phenoxy-tetrahydrofuran-2-yliden-methane verfahren zu ihrer herstellung sowie antimikrobielle mittel, die diese stoffe enthalten.
ATE291T1 (de) Fluorenyl-azolylmethyl-carbinole, verfahren zu ihrer herstellung, arzneimittel, die diese verbindungen enthalten und verfahren zur herstellung dieser arzneimittel.
ATE17727T1 (de) Alkylenverbrueckte guanidinothiazolderivate, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel.
ATE3421T1 (de) 1-alkadien-2,4-yl-2-hydroxymethyl-3,4,5trihydroxy-piperidine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
AT343616B (de) Verfahren zur herstellung des neuen 1,2,2,2-tetrafluorathyl - fluormethylathers
PT69999A (de) 1,2,3-triazolcarbonsaureamide verfahren zur herstellung dieser verbindungen sowie diese enthaltende biozide mittel
JPS567799A (en) Novel pseudotrisaccharide* its manufacture and use as medicine
ATE31928T1 (de) Acylamino-4-aza-1-adamantane, verfahren zu ihrer herstellung und ihre anwendung in der therapeutik.
ATE2794T1 (de) 1-n-alkylsisomicin-derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
ATE1583T1 (de) Neue 1,4-dihydropyridazin-3-carbonylverbindungen, verfahren zu ihrer herstellung, die verbindungen zur verwendung bei der behandlung von krankheiten, diese enthaltende arzneimittel und verfahren zur herstellung der arzneimittel.
ATE8621T1 (de) 6-keto-pge1- und pgi1-derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
NL7501607A (nl) Werkwijze ter bereiding van reukstofcomposities.
ATE14124T1 (de) Ringfoermige sulfenamide, verfahren zu ihrer herstellung, sie enthaltende arzneimittel und deren herstellung.
ATE1464T1 (de) N-amino-3,4,5-trihydroxypiperidine, verfahren zu ihrer herstellung, sie enthaltende arzneimittel, verfahren zu deren herstellung und die genannten verbindungen enthaltende tierfuttermittel.
AT293641B (de) Verfahren zur Herstellung des neuen 7α-Methyl-3,16α,17β-trihydroxy-Δ<1,3,5(10)>-oestratriens
ATE24718T1 (de) Alkylcycloalkyl-imidazolylmethyl-ketone und verfahren zu ihrer herstellung.